Study of SHR-A1811 in HER2-expression Advanced Breast Cancer With Brain Metastases
Status: RECRUITING
Study type: INTERVENTIONAL
Conditions: Metastatic Breast Cancer
Interventions: DRUG: SHR-A1811|DRUG: Pyrotinib|DRUG: Bevacizumab
Sponsor: Henan Cancer Hospital